19:45:11 EDT Fri 08 Aug 2025
Enter Symbol
or Name
USA
CA



Q:NEO - NEOGENOMICS INC - https://www.neogenomics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NEO - Q0.15.55·5.801.05.80+0.040.71,844.19,93011,1305.79  5.835  5.6319.115  4.7216:35:28Jul 3015 min RT 2¢

Recent Trades - Last 10 of 11130
Time ETExPriceChangeVolume
16:35:28Q5.725-0.0355
16:26:59Q5.780.0212
16:26:59Q5.780.02400
16:26:59Q5.770.01300
16:26:59Q5.75-0.01100
16:26:59Q5.75-0.01100
16:26:59Q5.75-0.01100
16:26:59Q5.75-0.01100
16:26:59Q5.75-0.01100
16:26:59Q5.76 4,288

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-07-30 07:05U:NEONews ReleaseNeoGenomics Launches PanTracer LBx, Expanding Access to Comprehensive Genomic Profiling with Liquid Biopsy
2025-07-29 07:05U:NEONews ReleaseNeoGenomics Reports Second Quarter 2025 Results
2025-07-01 07:05U:NEONews ReleaseNeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025
2025-06-30 07:05U:NEONews ReleaseNeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care
2025-06-24 07:05U:NEONews ReleaseNeoGenomics Appoints Dr. Marjorie Green to Board of Directors
2025-05-28 07:10U:NEONews ReleaseNeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025
2025-05-22 07:10U:NEONews ReleaseNeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer
2025-05-20 07:05U:NEONews ReleaseNeoGenomics to Participate in Upcoming June Investor Conferences
2025-05-01 07:05U:NEONews ReleaseNeoGenomics Pays Off 1.25% Convertible Senior Notes
2025-04-29 08:00U:NEONews ReleaseNeoGenomics and Ultima Genomics collaborate to expand clinical test offerings in Oncology using the UG 100 sequencing platform
2025-04-29 07:30U:NEONews ReleaseNeoGenomics Reports First Quarter 2025 Results
2025-04-22 07:05U:NEONews ReleaseNeoGenomics to Showcase PanTracer LBx Validation Study at AACR Annual Meeting
2025-04-08 07:05U:NEONews ReleaseNeoGenomics to Report First Quarter 2025 Financial Results on April 29, 2025
2025-04-07 07:05U:NEONews ReleaseNeoGenomics Completes Acquisition of Pathline
2025-04-01 07:05U:NEONews ReleaseTony Zook Assumes Role as Chief Executive Officer of NeoGenomics
2025-03-18 07:05U:NEONews ReleaseNeoGenomics Appoints Warren Stone as President & Chief Operating Officer
2025-03-10 07:00U:NEONews ReleaseNeoGenomics Expands Oncology Testing Reach in the Northeast with Acquisition of Pathline
2025-02-24 07:05U:NEONews ReleaseNeoGenomics to Participate in Upcoming Investor Conferences
2025-02-18 07:05U:NEONews ReleaseNeoGenomics Reports Fourth Quarter and Full Year 2024 Results
2025-01-30 09:05U:NEONews ReleasePacBio Announces Appointment of Chris Smith to Board of Directors